Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 3;103(18):e37847.
doi: 10.1097/MD.0000000000037847.

Echocardiographic manifestations of mitochondrial disease with GTPBP3 gene mutations: A case report

Affiliations
Case Reports

Echocardiographic manifestations of mitochondrial disease with GTPBP3 gene mutations: A case report

Qiaoli Tong et al. Medicine (Baltimore). .

Abstract

Rationale: Mitochondrial diseases are a group of disorders in which mutations in mitochondrial DNA or nuclear DNA lead to dysfunctional oxidative phosphorylation of cells, with mutations in mitochondrial DNA being the most common cause of mitochondrial disease, and mutations in nuclear genes being rarely reported. The echocardiographic findings of mitochondrial diseases with nuclear gene mutations in children's hearts are even rarer. Even more valuable is that we followed up the patient for 4 years and dynamically observed the cardiac echocardiographic manifestations of mitochondrial disease. Provide ideas for the clinical diagnosis and prognosis of mitochondrial diseases.

Patient concerns: The patient was seen in the pediatric outpatient clinic for poor strength and mental retardation. echocardiography: mild left ventricular (LV) enlargement and LV wall thickening. Nuclear genetic testing: uanosine triphosphate binding protein 3 (GTPBP3) gene mutation. Diagnosis of mitochondrial disease.

Diagnoses: Mitochondrial disease with GTPBP3 gene mutations.

Outcomes: After receiving drug treatment, the patient exhibited a reduction in lactate levels, an enhanced physical condition compared to prior assessments, and demonstrated average intellectual development.

Lessons subsections: For echocardiographic indications of LV wall thickening and LV enlargement, one needs to be alert to the possibility of hereditary cardiomyopathy, especially in children.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
The findings of pedigree Sanger sequencing analysis were as follows. (A) The proband carried homozygous mutations on the GTPBP3 gene; (B) the father of the proband exhibited heterozygous mutations on the GTPBP3 gene; (C) the mother of the proband also had heterozygous mutations on the GTPBP3gene. GTPBP3 = guanosine triphosphate binding protein 3.
Figure 2.
Figure 2.
Cranial MRI showed that there were abnormal signs (White arrow) in right frontal. (A) and left parietal areas as well as symmetrical abnormal signals in bilateral cerebellum. (B and C) and corpora quadrigemina. MRI = magnetic resonance imaging.
Figure 3.
Figure 3.
The echocardiography when the child was 10 revealed reduced LV-GLS. GLS = global longitudinal strain, LV = left ventricular.

Similar articles

References

    1. Meyers DE, Basha HI, Koenig MK. Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J. 2013;40:385–94. - PMC - PubMed
    1. Holmgren D, Wåhlander H, Eriksson BO, et al. . Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J. 2003;24:280–8. - PubMed
    1. Scaglia F, Towbin JA, Craigen WJ, et al. . Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004;114:925–31. - PubMed
    1. El-Hattab AW, Scaglia F. Mitochondrial Cardiomyopathies. Front Cardiovasc Med. 2016;3:25. - PMC - PubMed
    1. Peng GX, Zhang Y, Wang QQ, et al. . The human tRNA taurine modification enzyme GTPBP3 is an active GTPase linked to mitochondrial diseases. Nucleic Acids Res. 2021;49:2816–34. - PMC - PubMed

Publication types

Substances